1.Discussing the diagnostic value of troponin in the acute myocardial infarction after cardiac surgery
Linbao LIANG ; Guodong CHENG ; Chunlei ZHU ; Guofeng CHEN ; Naiying CHEN ; Wei HUANG
Chinese Journal of Postgraduates of Medicine 2014;37(14):4-5
Objective To research the diagnostic value of troponin in the acute myocardial infarction after cardiac surgery.Methods The prospective study method was used.One hundred and thirtyfour patients of cardiac surgery were selected as observation group,36 patients of thoracic surgery were selected as control group.All the patients were given continuous electrocardiogram monitoring and measured troponin I,and the results were compared between the 2 groups.Results There was no statistical difference in the troponin I before anesthesia between the 2 groups (P > 0.05).The troponin I 4 h after surgery was (13.010 ± 14.829) μg/L in observation group,(0.019 ± 0.007) μg/L in control group,there was statistical difference (P < 0.05).One case of observation group happened the acute myocardial infarction after cardiac surgery,the troponin I was > 40.000 μ g/L.Conclusions The troponin is obviously increased in the early stage in most patients of cardiac surgery,the false positive rate in diagnostic acute myocardial infarction is higher according to the troponin.For troponin,it will need the more evidence of evidence-based medicine to establish the diagnosis of acute myocardial infarction after cardiac surgery.
2. Continued circulation and phylogenetic analysis of human adenovirus-55 in China during 2006-2016
Naiying MAO ; Zhen ZHU ; Zhenqiang LEI ; Yan LI ; Fang HUANG ; Jie YIN ; Meng CHEN ; Xingyu XIANG ; Hong LI ; Liuying TANG ; Aili CUI ; Zhong LI ; Ti LIU ; Wenbo XU
Chinese Journal of Experimental and Clinical Virology 2018;32(2):124-129
Objective:
To better understand the evolution and epidemiology of human adenovirus-55 (HAdV-55) and provide a scientific basis for the prevention and control of the epidemic of HAdV-55 in China.
Methods:
HAdV-55 isolates from 5 provinces in China included Beijing, Hebei, Shandong, Hunan and Yunnan were collected during 2011-2014. The hexon, fiber and penton base gene were sequenced, and compared with other strains of HAdV-55 sequences downloaded from GenBank for homology and evolution analysis.
Results:
During the past decade, HAdV-55 was found in 15 provinces throughout China. Genetic and phylogenetic analysis showed that the HAdV-55 virus is highly conservative in evolution due to aggregation in a branch in the evolutionary tree. However, bayesian phylogenetic tree shows a certain time evolution trend. The evolution rate of hexon and fiber gene of HAdV-55 are 5.228×10-5 and 1.238×10-4 substitutions/site/year respectively, and the latest coevolutionary ancestor tMRCA of hexon gene can be traced back to 1963.
Conclusions
HAdV-55 has been widely spread and continued circulating in China. Establishing effective monitoring system and conducting vaccine related research is very important for its control and prevention.
3.Distribution and infectious characteristics of re-positive cases infected with SARS-CoV-2.
ZhiLi LI ; Yu LI ; QiuLan CHEN ; XiaoKun YANG ; HongTing ZHAO ; XinLi JIANG ; SiMeng FAN ; Dan LI ; Ying QIN ; ZhiBin PENG ; JianXing YU ; NaiYing MAO ; ZhongJie LI
Chinese Journal of Epidemiology 2021;42(10):1750-1756
Domestic and foreign literatures related to the persistence of SARS-CoV-2 and the re-positive cases infected with SARS-CoV-2 were reviewed, and the characteristics and infectivity of the re-positive cases were analyzed to provide scientific evidence for the improvement of case management and the development of measures to stop the spread of SARS-CoV-2. Existing studies have shown that re-positive rate of SARS-CoV-2 ranged from 2.4% to 19.8%, the median of interval between re-positive detection and discharge was 4-15 days. Following the second course of the disease, the anti-SARS-CoV-2 IgM, IgG and IgA positive rates of the cases were 11.11%-86.08%, 52.00%-100.00% and 61.54%-100.00% respectively, the total antibody and neutralizing antibody positive rates were 98.72% and 88.46%. The viral load of the re-positive cases was lower than that in the initial infection. At least 3 380 re-positive cases have been reported globally. SARS-CoV-2 strains were isolated from the samples of 3 re-positive cases (1 immunodeficiency case and 2 cases with abnormal pulmonary imaging). There were close contacts that were infected by an asymptomatic case taking immunosuppressive agents. In conclusion, the infectivity of re-positive cases infected with SARS-CoV-2 is generally very low. Rare re-positive cases infected with SARS-CoV-2 might cause further transmission. The management approach for the re-positive cases can be based on the assessment of the individual transmission risk according to the pathogen detection results.
Antibodies, Neutralizing
;
Antibodies, Viral
;
COVID-19
;
Humans
;
Immunoglobulin M
;
SARS-CoV-2